The Insulin Receptor Substrate (IRS) adaptor proteins IRS1 and IRS2 play essential roles in regulating the response of breast and other tumor cells to signaling through the insulin (IR) and Insulin-like Growth Factor-1 (IGF-1R) receptors, as well as to some integrin and cytokine receptors (1, 2). Here, IRS2 is linked to neoplasm.